MAS is classified as a form of secondary HLH and shares elevation of biomarkers of IFN-ɣ activity (like CXCL9) with primary HLH [4, 9, 15], consistent with the role of IL-18 as a potent amplifier of IFN- ɣ production. Here, IFNA1 is linked to macrophage activation syndrome.